Equities
  • Price (EUR)0.206
  • Today's Change0.00 / 0.00%
  • Shares traded2.63k
  • 1 Year change+6.19%
  • Beta0.9776
Data delayed at least 15 minutes, as of Feb 06 2026 07:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Ausnutria Dairy Corp Ltd is an investment holding company principally engaged in the research and development, production, marketing and distribution of dairy and related products and nutrition products. The Company operates its business through two segments. The Dairy and Related Products segment is mainly engaged in the manufacturing and sale of dairy and related products, particularly on formula milk powder products. The Nutrition Products segment is mainly engaged in the manufacturing and sale of nutrition products (mainly including probiotic related products and gut relief products). The Company’s products include goat milk formulas (Kabrita), cow milk formulas (Hyproca) and others. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)8.56bn
  • Net income in HKD305.03m
  • Incorporated2009
  • Employees3.26k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.